Renal denervation: one step backwards, three steps forward

被引：0
|
作者：
Markus P. Schlaich
George L. Bakris
机构：
[1] University of Western Australia,Dobney Hypertension Centre, School of Medicine — Royal Perth Hospital Unit
[2] Royal Perth Hospital,Departments of Cardiology and Nephrology
[3] Baker Heart and Diabetes Institute,Neurovascular Hypertension & Kidney Disease Laboratory
[4] University of Chicago Medicine,Comprehensive Hypertension Center, Department of Medicine
来源：
Nature Reviews Nephrology | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Many considered the failure of the SYMPLICITY HTN-3 trial to represent the end of therapeutic renal denervation. However, promising preliminary data from the SPYRAL HTN-OFF MED study and more recently the SPYRAL HTN-ON MED and RADIANCE-HTN SOLO studies support the efficacy of this intervention for blood pressure lowering in patients with hypertension.
引用
收藏
页码：602 / 604
页数：2
相关论文
共 50 条
12345